# CVE-2024-2275: Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting

> Remote attackers can inject malicious scripts via patient prescription fields in Bdtask G-Prescription software, potentially compromising user sessions.

- **Severity:** Low 2.4 (`CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N`)
- **Exploited in the wild:** Not known
- **Login needed:** An administrator
- **Attackable:** Over the internet
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 8 Mar 2024
- **Updated:** 1 Aug 2024
- **Also known as:** GHSA-8c2p-fm7f-34m4

## What is CVE-2024-2275?

CVE-2024-2275 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology & OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.

### Official description

A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Weakness: CWE-79 (Improper Neutralization of Input During Web Page Generation)

## Which versions are affected by CVE-2024-2275?

It affects 1 product.


Products: Bdtask G-Prescription Gynaecology \& Obs Consultation.

## How do I fix CVE-2024-2275?

No fix has been published for CVE-2024-2275 yet. Limit exposure of the affected software until one is available.

## Is CVE-2024-2275 being exploited?

There is no known exploitation of CVE-2024-2275 in the wild and no public exploit code.

## Other vulnerabilities in Bdtask G-Prescription Gynaecology & OBS Consultation Software

- [CVE-2024-2277](https://insights.sbomify.com/CVE-2024-2277/): Cross-site request forgery in G-Prescription Gynaecology & OBS Consultation Software (medium 4.3)
- [CVE-2024-2274](https://insights.sbomify.com/CVE-2024-2274/): Bdtask G-Prescription Gynaecology & OBS Consultation Software Prescription Dashboard Index cross site scripting (low 2.4)
- [CVE-2024-2276](https://insights.sbomify.com/CVE-2024-2276/): Bdtask G-Prescription Gynaecology & OBS Consultation Software Edit Venue Page cross site scripting (low 2.4)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2024-2275 and fix it if it is affected.

What it is: CVE-2024-2275 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology & OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.
Exploitation: There is no known exploitation of CVE-2024-2275 in the wild and no public exploit code.

Affected product: Bdtask G-Prescription Gynaecology & OBS Consultation Software. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2024-2275/ (Markdown: https://insights.sbomify.com/CVE-2024-2275/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2024-2275
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2024-2275
- OSV: https://osv.dev/vulnerability/CVE-2024-2275

---
From sbomify Insights: https://insights.sbomify.com/CVE-2024-2275/
Summaries are generated and may contain mistakes; the official description above is the record.